50474-983 : Rystiggo 140 mg/ml Subcutaneous Injection, Solution
| NDC: | 50474-983 |
| Labeler: | Ucb, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Rystiggo |
| Dosage Form: | Subcutaneous Injection, Solution |
| Application #: | BLA761286 |
| Rev. Date: |
NDC Package Codes:
- 50474-983-86: 1 VIAL, GLASS IN 1 CARTON (50474‑983‑86) / 6 ML IN 1 VIAL, GLASS
Active Ingredients:
- Rozanolixizumab
Dosage Strength:
- 140 mg/mL
Pharmaceutical Classes:
- Neonatal Fc Receptor Blocker [EPC]
- Neonatal Fc Receptor Blockers [MoA]
Related Products:
Based on records with the same trade name.- 50474-980 Rystiggo 140 mg/ml Subcutaneous Injection, Solution by Ucb, Inc.
- 50474-981 Rystiggo 140 mg/ml Subcutaneous Injection, Solution by Ucb, Inc.
- 50474-982 Rystiggo 140 mg/ml Subcutaneous Injection, Solution by Ucb, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50474-982Next: 50474-990 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.